You are here

Pfizer

FTC investigates J&J contracts regarding the drugmaker's blockbuster Remicade

Endpoints

Tue, 07/30/19 - 07:59 am

With Mylan deal, Pfizer seeks faster growth via innovation focus

BioCentury

Mon, 07/29/19 - 11:23 pm

What The Pfizer-Mylan Deal Means For Pharma

Forbes

Mon, 07/29/19 - 11:17 pm

Mylan CEO Heather Bresch to retire after deal to merge with Pfizer's Upjohn closes

Marketwatch

Mon, 07/29/19 - 09:48 am

Pfizer (PFE) Q2 Earnings Top Estimates

NASDAQ

Mon, 07/29/19 - 09:37 am

After painting a poor safety profile, Pfizer and Eli Lilly are shooting for a new pain drug OK anyway

Endpoints

Mon, 07/29/19 - 09:30 am

Pfizer and Mylan: Is Mega-Merger on the Horizon?

Market Realist

Mon, 07/29/19 - 09:23 am

Pfizer in talks to merge off-patent drugs business with Mylan -source

Yahoo/Reuters

Sat, 07/27/19 - 02:13 pm

Following EMA, FDA restricts use of high-dose Xeljanz, warning of added risks for the blockbuster JAK

Endpoints

Fri, 07/26/19 - 11:14 am

Lyrica Patent Expiration Ushers In 9 Generic Competitors

Xtalks

Thu, 07/25/19 - 07:06 pm

Alembic Pharmaceuticals

Alkem Laboratories

MGN Laboratories

Rising Pharmaceuticals

Sciegen Pharmaceuticals

Teva Pharmaceutical

Elizabeth Warren presses Pfizer to fork over information on Scott Gottlieb

Stat

Wed, 07/24/19 - 10:01 pm

Elizabeth Warren

FDA approves Rituxan biosimilar

Beckers Hospital Review

Tue, 07/23/19 - 07:40 pm

autoimmune disease

Lyrica generics roll: Pfizer blockbuster finally hits patent cliff

Fierce Pharma

Mon, 07/22/19 - 08:10 pm

8 More Big Pharma Events in 2019 You Don't Want to Miss

Motley Fool

Mon, 07/22/19 - 09:44 am

Bristol-Myers Squibb

Pfizer's keys to juggling 8 U.S. launches? Organization, accountability, clear goals

Fierce Pharma

Fri, 07/19/19 - 01:19 pm

As it preps Phase III kidney trial on its own, AM-Pharma raises €116M series C

BioCentury

Tue, 07/16/19 - 11:03 am

acute kidney injury

Pfizer's Xeljanz drops off top June TV spenders list—and Gilead's Biktarvy fills the void

Fierce Pharma

Thu, 07/11/19 - 09:45 am

Gilead Sciences

Novartis amps up Symjepi launch to fill Pfizer's EpiPen supply gap

Fierce Pharma

Wed, 07/10/19 - 11:34 am

Adamis Pharmaceuticals

Billions on the line: BioMarin bustles past enthused rival, planning to launch world’s first hemophilia A gene therapy

Endpoints

Mon, 07/8/19 - 08:13 pm

Sangamo backs up early success for hemophilia gene therapy

Biopharma Dive

Sat, 07/6/19 - 01:36 pm

Spark Therapeutics

Pages